Aged care reform continued over the holiday period, with two important regulatory changes taking effect from 1 January 2020.
Firstly, the aged care regulatory functions of the Department of Health were transferred to the Aged Care Quality and Safety Commissioner.
And secondly, from 1 January 2020, doctors be required to apply for additional approval if the drug Risperidone is prescribed for a period longer than 12 weeks.
The changes form part of the government’s initial response to the Royal Commission into Aged Care Quality and Safety’s Interim Report.
Shifting the Department of Health’s aged care regulatory functions to the ACQSC means the full suite of regulatory functions that relate to providers of aged care services are under one roof.
The ACQSC will now regulate:
The move is intended to remove duplication in the management of non-compliance with the standards. It will also allow for graduated and escalating responses to non-compliance with the standards, and streamline the performance assessment process, providing greater clarity to consumers and transparency for providers.
Having all aged care regulation under one banner – a one-stop shop for aged care regulation – was a key recommendation of the Carnell Paterson Review.
The change was legislated with the passing of the Aged Care Legislation Amendment (New Commissioner Functions) Act 2019 which was only passed on 5 December 2019.
The second change, additional regulation around the use of psychotropic medication, comes after the royal commission’s interim report recommended a response “to the significant over-reliance on chemical restraint in aged care”.
From 1 January 2020, doctors will have to apply for additional approval if the medication is required to be taken for longer than 12 weeks.
Minister for Aged Care, Richard Colbeck, said in a statement, “The Royal Commission identified an over-reliance on chemical restraint as a priority concern in aged care and the Government has taken this action among other measures to ensure senior Australians receive the care they expect and deserve.”
Additional education resources for prescribers are also being developed to support the appropriate use of antipsychotics and benzodiazepines in residential aged care, Mr Colbeck said.
The government is continuing to review other aged care reforms, including developing a new funding model, but will not finalise them until the royal commission releases its final recommendations.
“It is important that the key long term challenges investigated by the royal commission are explored thoroughly to ensure the development of a sturdy response and recommendations for future reform,” said Mr Colbeck.
The Royal Commission’s Final Report is due to be delivered by 12 November.
A very well written content Caroline. As a registered nurse in the aged care sector, I take an obvious interest in the ongoing (and very regular) changes in the industry. Our industry is growing and changing faster than we can keep up and its only set to become bigger. This article by Economist Dan Hadley here in Adelaide released last week talks about the Ageing Population of Australia and points out the increasing need of resources to keep up. https://businessacumen.biz/54-acumen-leader/4551-australia-s-ageing-population-pressure-that-s-only-set-to-rise
Caroline, do you think there will be a corresponding increase in regulations and industry requirements as things get more constrained?